A Clinical study to evaluate the efficacy of Ayurvedic drug in the treatment of renal stones

A Randomized Controlled Clinical trial to Study the Efficacy of Kadali Kwath in Comparison with Varunadi Kwath in the Management of Mutrashmari

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/03/051228

Enrollment

Registered

2023-03-31

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N202- Calculus of kidney with calculus of ureter

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients having signs and symptoms of Mutrashmari. 2) Urolith of size up to 12 mm. 3) Genders : Both Males and females 4) Patients between age group 18 to 60 years will be included. 5) Urolith seen in urinary tract as per USG.

Exclusion criteria

Exclusion criteria: 1) Seriously ill patients. 2) Obstructive uropathy leading to gross hydronephrosis, renal function impairment. 3) Pyonephrosis, 4) CA of urinary tract. 5) Gross hematuria.(Visible blood in the urine) 6) Having Urolith of size more than 12mm. 7) Pregnant and lactating women. 8) Patients with no symptoms of mutrashmari

Design outcomes

Primary

Measure	Time frame
To study the effect of Kadali Kwath in comparison with Varunadi Kwath in the management of Mutrashmari/ UrolithiasisTimepoint: Duration of treatment 30 days Follow up on 15th and 30th days	—

Secondary

Measure	Time frame
To assess the effect of Kadali kwath in Mutrashmari( Renal and Ureteric stone) with expulsion of stoneTimepoint: Duration of treatment 30 days Follow up on 15th and 30 th days	—

Countries

India

Contacts

Public ContactDrAshok Devidas Pawar

Tilak Ayurved Mahavidyalaya Pune

drnvborse@gmail.com9422032696

Outcome results